Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155534 | SCV000205233 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Phe1497Phe in exon 36 of DOCK8: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.4% (38/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs7854035). |
Labcorp Genetics |
RCV005089754 | SCV001727201 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001518498 | SCV001762991 | benign | Combined immunodeficiency due to DOCK8 deficiency | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000155534 | SCV004101856 | benign | not specified | 2023-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 100% of patients studied by a panel of primary immunodeficiencies. Number of patients: 96. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV004712149 | SCV005270477 | benign | not provided | criteria provided, single submitter | not provided |